Afficher la couverture 'Serum ceramides could predict durable diabetes remission following gastric bypass surgery | Hajduch, Eric' en grand format
/5

0 avis

Serum ceramides could predict durable diabetes remission following gastric bypass surgery

Archive ouverte

Hajduch, Eric | Le Stunff, Hervé

Edité par CCSD ; Cell Press -

International audience. Morbid obesity is a major risk factor for the development of type 2 diabetes (T2D). One strategy to both lose weight and counteract T2D is bariatric surgery (RYGB). In a study published in this issue of Med, Poss et al. revealed that circulating ceramides could predict the durability of T2D remission independently of weight loss following RYGB.

Consulter en ligne

Suggestions

Du même auteur

Circulating Sphingolipids and Glucose Homeostasis: An Update

Archive ouverte | Ali-Berrada, Sarah | CCSD

International audience. Sphingolipids are a family of lipid molecules produced through different pathways in mammals. Sphingolipids are structural components of membranes, but in response to obesity, they are implic...

Inverse relationship between circulating sphingosine-1-phosphate and precursor species and coronary artery calcification score in type 2 diabetes

Archive ouverte | Le Goff, Wilfried | CCSD

International audience. Abstract Background Sphingosine 1-phosphate (S1P) is a key mediator of lipid signaling with strong immunomodulatory and anti-inflammatory effects. Circulating S1P levels including S1P in high...

Ceramide Transporter CERT Is Involved in Muscle Insulin Signaling Defects Under Lipotoxic Conditions

Archive ouverte | Bandet, Cécile, L | CCSD

International audience. One main mechanism of insulin resistance (IR), a key feature of type 2 diabetes, is the accumulation of saturated fatty acids (FAs) in the muscles of obese patients with type 2 diabetes. Unde...

Chargement des enrichissements...